Drug development is a very hard and long process. Going through all the scientific and regulatory steps is a long and critical process and confident and reliable partnership has to be implemented between the different actors.
First preclinical stage aims at screening a large range of drug candidates, select the most promising one(s) and then go further on.
Atlantic Bone Screen’s services are dedicated to help its Customers in the selection of the right drug candidate by evaluating their toxicity, efficacy, release…
In-vitro and in-vivo assays enable such evaluation and thanks to our technical platform and our scientific expertise in the field of bone and joint diseases, Atlantic Bone Screen can propose several models for bone and joint diseases research, for tumoral or non tumoral diseases.
